Credence Research Logo

Home » Healthcare » Automated & Closed-Cell Therapy Processing Systems Market

Automated & Closed-Cell Therapy Processing Systems Market By System Type (Cell Expansion Systems, Cell Harvesting Systems, Cell Separation and Sorting Systems, Cell Washing and Concentration Systems, Closed System Cryopreservation Systems, Others) By Application (CAR-T Cell Therapy, Stem Cell Therapy, Other Cell-Based Therapies) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 22244 | Report Format : PDF

Market Insights

  • The global demand for automated and closed cell therapy processing systems was valued at USD 944.9 Million in 2022 and is expected to reach USD 3673.9 Million in 2030, growing at a CAGR of 18.5% between 2023 and 2030.
  • The cell expansion systems segment is the market leader by system type, accounting for more than 30% of total value in 2022, while the cell harvesting systems segment is estimated to grow rapidly in the projection period.
  • The CAR-T cell therapy application category is expected to expand quickly in the forecast period, while the stem cell therapy segment has the greatest market share in 2022.
  • The small-scale systems scale dominates the global need for automated and closed cell therapy processing systems, accounting for more than 58% in 2022 and is predicted to expand at a high CAGR.
  • The pharmaceutical & biotechnology companies category dominated the market with 40% of the total revenue share by end-users. In contrast, the academic & research institutions category will expand fastest during the projected time frame.
  • North America is driving the growth of the automated & closed-cell therapy processing systems market, accounting for more than one-third of the market in 2022, while Asia Pacific and Europe account for just under 54% of the global market in 2022. Europe had a market revenue share of more than 20% in 2022.
  • The increasing integration of software-based technologies and advanced therapy manufacturing processes is expected to fuel market developments.
  • Automated & closed cell therapy processing systems are widely utilized to control and sustain the cell therapy process. These systems incorporate manufacturing software and hardware that helps in every step of the R&D process.
  • Technologies related to cell therapy are critical to the field of medicine and cell therapy, which has become an essential component of medical practices.

Executive Summary

Market Definition

The automated & closed-cell therapy processing systems market refers to the industry sector focusing on the research, manufacture, and commercialization of specialized systems and equipment meant to automate and expedite the processing of cellular materials for cell-based treatments. These systems are engineered to handle various aspects of cell therapy manufacturing, including cell isolation, expansion, modification, and final product formulation while ensuring a closed and controlled environment to maintain cell quality and minimize contamination risks. Automated and closed cell therapy processing systems play a key role in advancing the field of regenerative medicine and cellular therapies by improving process efficiency, reproducibility, and the safety and quality of therapeutic cell products.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Overview

The global automated & closed-cell therapy processing systems market has witnessed rapid growth in recent years and is expected to grow at a CAGR of 18.5% between 2023 and 2030. The market was valued at USD 944.9 million in 2022 and is expected to reach USD 3673.9 million in 2030.

The worldwide pharmaceutical sector has benefited enormously from automation in cell therapy processing or manufacturing systems. Cells are selected, extracted, modified, and widened as part of the cell therapy manufacturing process. In this delicate process, even little errors can result in improper cell infusion. The automated and closed cell therapy processing procedures lower the risk of the end product. Automation reduces the risk of contamination caused by manual labor in cell therapy processing. The automated & closed-cell treatment processing system reduces the probability of errors during bioprocessing, reducing the amount of cell operations.

The growing global prevalence of cancer has boosted demand for automated and closed cell therapeutic processing systems. In 2020, 4.39 million new cases of cancer were predicted in Europe, according to a report by the Global Cancer Observatory. Fully automated cell therapy processing systems are designed to deliver powerful processing with enhanced therapeutics for essentially incurable diseases. Leading companies in the global market are assisting in the expansion by providing cutting-edge platforms for cell therapy production procedures. Clinical trials for innovative medicines have increased tremendously in recent years.

Segmentation by System Type

  • The cell harvesting systems segment is anticipated to demonstrate the highest CAGR in the forecast period. These systems play a major role in isolating and collecting therapeutic cells, offering efficient and closed processes for cell therapy manufacturing.
  • Currently, cell expansion systems hold the largest market share, accounting for over 30% in 2022. Cell expansion systems are important for amplifying cell populations, ensuring a consistent and scalable supply of cells for various therapies and applications.

Segmentation by Application

  • The stem cell therapy category is likely to register the highest CAGR. Stem cell therapies hold immense promise for regenerative medicine and treating a range of diseases, driving the demand for advanced processing systems.
  • In 2022, CAR-T cell therapy led the market, with a substantial share of over 44%. CAR-T therapies have gained significant traction in cancer treatment, contributing to their dominant market position.

Segmentation by End User

  • Pharmaceutical & biotechnology companies constitute the dominant category, accounting for more than 40% of the global automated and closed cell therapy processing systems market demand in 2022. Pharmaceutical and biotechnology companies rely on these systems for efficient and compliant manufacturing of cell-based therapies.
  • Academic and research institutions fulfill the remaining market needs, leveraging these systems for cutting-edge research and development in the field of cell therapies.

Segmentation by Scale

  • Large-scale systems are projected to exhibit the highest CAGR, reflecting the increasing demand for industrial-scale cell therapy manufacturing to meet global healthcare needs.
  • Currently, small-scale systems lead the market share, accounting for over 58% in 2022. These systems are essential for research, early-stage clinical trials, and personalized medicine applications.

Segmentation by Region

  • North America’s robust healthcare facilities and R&D capabilities make it a highly lucrative region, holding over one-third of the global automated and closed cell therapy processing systems market share in 2022. This region continues to drive innovation and adoption in the cell therapy processing field.
  • Collectively, Asia Pacific and Europe contribute to nearly 54% of the market share, with the Asia Pacific region displaying significant growth potential. These regions are witnessing substantial investments in healthcare infrastructure and biotechnology research, promoting market expansion.
  • Europe’s substantial share of over 20% in the same year reflects its established medical facilities and robust market presence, particularly in cell therapy research and development.
  • The rest of the world, encompassing regions like Latin America, the Middle East, and Africa, contributes to the remaining demand for automated and closed cell therapy processing systems, offering untapped growth opportunities in emerging markets. These regions are increasingly adopting cell therapies and corresponding processing technologies, representing a growing market frontier.

The market for automated & closed-cell therapy processing systems is expected to rise as a result of the rising popularity of regenerative medicine and cell therapies on a worldwide scale, as well as the numerous advantages that automation technologies provide for the development of these therapies.

North America dominates the global automated and closed cell therapy processing systems market mainly due to its advanced healthcare infrastructure and extensive R&D activities. The region is home to numerous pioneering biopharmaceutical companies, research institutions, and academic centers, promoting a culture of innovation and technological advancement. Besides, North America benefits from a well-established regulatory framework that encourages the adoption of advanced manufacturing technologies, ensuring compliance and quality assurance. The presence of a substantial patient population, particularly in the U.S., further fuels the demand for cell-based therapies, necessitating efficient and scalable manufacturing solutions like automated and closed processing systems.

The Asia Pacific region is experiencing a surge in the adoption of cell-based therapies for various medical conditions, including cancer and degenerative diseases. Many countries in the Asia Pacific are investing heavily in expanding and upgrading their healthcare infrastructure. This includes the establishment of cutting-edge research centers, biotechnology hubs, and manufacturing facilities, creating a conducive environment for the adoption of advanced cell therapy processing technologies. The region is also home to a large and aging population, which is more susceptible to chronic diseases and age-related conditions. This demographic trend is fueling the demand for innovative medical treatments, including cell-based therapies, thus increasing the market share for automated and closed processing systems.

Key Highlights of the Report

The global automated & closed-cell therapy processing systems market is segmented by system type, application, end-user, scale, and region. Cell harvesting systems are on a trajectory for substantial growth, facilitating efficient cell isolation and collection. Meanwhile, cell expansion systems currently dominate the market, ensuring scalable cell production. Stem cell therapy applications are poised for substantial growth, indicating their increasing importance in regenerative medicine. CAR-T cell therapy leads the market, particularly in cancer treatments. Pharmaceutical & biotechnology companies represent the dominant end-users, relying on these systems for compliant manufacturing. Academic & research institutions also play a vital role in advancing cell therapies. Large-scale systems are gaining momentum for industrial-scale production, while small-scale systems remain crucial for research and personalized medicine.

The growing need for cell-based medicines, as well as the need for efficient, compliant, and scalable production processes, are driving the global automated and closed cell therapy processing systems market. Continuous technological developments in automation, real-time monitoring, and single-use technologies are transforming the market landscape, increasing efficiency, lowering costs, and maintaining consistent product quality. The trend towards personalized medicine is increasing demand for small-scale systems adapted to individualized cell therapy production, which plays an important role in advancing customized treatments. However, the market faces challenges, including higher treatment costs, complex manufacturing processes, and regulatory limitations that can hinder the widespread adoption of these therapies.

North America led the automated and closed cell therapy processing systems market and accounted for the largest global revenue share in 2022. This high share is majorly attributed to the emerging technological adoption for cell therapy processing and the focus on high precision & production throughput. The rising investments by market players, as well as research institutions, are also expected to play a key role in regional growth. On the other hand, increased government & private investments, expanding healthcare requirements, and the introduction of faster approval pathways are the primary driving factors for the market’s remarkable expansion in Asia Pacific.

What Are The Main Drivers Of The Global Automated & Closed-Cell Therapy Processing Systems Market?

The main drivers of the global automated and closed cell therapy processing systems market include the rising demand for advanced cell-based therapies, such as CAR-T cell therapies and regenerative medicine, which necessitate automated solutions to meet production demands. These systems offer advantages like reduced contamination risk and enhanced product consistency, thereby boosting their adoption. Besides, increasing investments in research & development, collaborations between biopharmaceutical companies and technology providers, and the imperative to meet stringent regulatory requirements are propelling innovation in automated cell therapy processing. The expanding awareness of the benefits of automation and the need for scalable and reproducible manufacturing processes further drive the market’s growth.

What Are The Major Challenges Faced By The Global Automated & Closed-Cell Therapy Processing Systems Market?

The major challenges faced by the global automated & closed-cell therapy processing systems market include the high manufacturing costs associated with these specialized systems, limiting their accessibility and affordability for smaller biotech companies and research institutions. Additionally, ensuring seamless scalability while maintaining consistent product quality remains a complex challenge, particularly for large-scale production. Stringent regulatory requirements and the need for comprehensive validation processes also pose limitations to system development and adoption. Furthermore, as the field of cell therapy evolves, there is a continual need to keep pace with changing technologies and adapt to emerging therapies, which can be resource-intensive for manufacturers.

What Are The Growth Opportunities In The Global Automated & Closed-Cell Therapy Processing Systems Market?

The global automated and closed cell therapy processing systems market offers substantial growth opportunities, primarily driven by the increasing adoption of cell-based therapies and the continuous advancements in technology. Scalability remains a significant growth avenue as manufacturers seek to produce larger quantities of consistent cell therapies to meet rising demand. The integration of single-use technologies and advanced monitoring and control systems is enhancing process efficiency while reducing costs. Moreover, expanding awareness of the benefits of automated and closed systems, particularly in minimizing contamination risks and ensuring product quality, is likely to drive market expansion. Collaborations between biopharmaceutical companies and technology providers to develop innovative solutions also present growth prospects, particularly as the regulatory landscape evolves to support these advanced manufacturing methods.

Market Drivers

Several factors drive the global automated and closed cell therapy processing systems market. The following are the key drivers of the global automated & closed-cell therapy processing systems market:

Increased Adoption of Cell-Based Therapies

The rising adoption of cell-based therapies is a major driver for the market growth of automated and closed cell therapy processing systems. Cell therapies, such as CAR-T cell therapies and stem cell treatments, have shown remarkable potential in treating various diseases, including cancer, autoimmune disorders, and degenerative conditions. According to the latest study (issued by The Alliance for Regenerative Medicine), over 1,000 companies are now conducting clinical studies focusing on the evaluation of cell and gene therapies around the world.

As these therapies advance through clinical trials and gain regulatory approvals, there is a growing need for efficient and standardized manufacturing processes. Automated and closed processing systems offer several advantages, including reduced contamination risk, enhanced reproducibility, and improved cell quality, making them essential for meeting the increasing demand for cell-based therapies.

Market Restraints

The global automated & closed-cell therapy processing systems market faces challenges that may hinder its growth. These include the following:

High Initial Investment Costs

One of the primary restraints is the higher initial investment required for acquiring and implementing automated and closed cell therapy processing systems. These systems are technologically sophisticated and incorporate advanced equipment, software, and specialized materials to ensure a closed and controlled processing environment. The substantial upfront costs associated with purchasing, installing, and validating these systems can be a barrier, particularly for smaller biotech companies, research institutions, and facilities in emerging markets. High capital expenditure often necessitates careful budget planning and financial considerations, limiting the accessibility of these systems to a broader range of users.

Opportunities

The global automated & closed-cell therapy processing systems market offers significant growth opportunities. These include the following:

Innovation in Single-Use Technologies

The development and integration of single-use technologies present a notable opportunity in the automated and closed cell therapy processing systems market. Single-use components, such as bioreactors and disposable bags, offer advantages such as reduced cross-contamination risks and simplified validation processes. As the industry continues to prioritize cost-effectiveness, scalability, and flexibility, the adoption of single-use technologies is expected to increase. Companies that invest in innovative single-use solutions and offer comprehensive integration with existing automated systems can cater to the evolving needs of manufacturers. This presents an opportunity to enhance system efficiency, reduce operating costs, and address the demand for adaptable and cost-effective manufacturing solutions in the cell therapy sector.

Competitive Landscape

Key Players

The competitive landscape of the global automated and closed cell therapy processing systems market is characterized by intense competition among a growing number of technology providers and system developers. The following are some of the top market players and their market shares:

  • Miltenyi Biotec
  • Lonza
  • Fresenius Kabi
  • Cytiva (Danaher Corp.)
  • BioSpherix Ltd
  • Terumo Corp.
  • Sartorius AG
  • ThermoGenesis Holdings Inc
  • Cellares Inc
  • Thermo Fisher Scientific Inc
  • Others

These leading market players continually strive to innovate and develop cutting-edge automated and closed systems to stay ahead. This includes the integration of advanced monitoring, control, and sensor technologies. They are also expanding their geographic reach to tap into emerging markets in regions like the Asia Pacific, where cell therapy adoption is growing rapidly. Market players often broaden their product portfolios to cover various aspects of cell therapy processing, from cell isolation and expansion to final product formulation, aiming to offer comprehensive solutions. Technological alliances and collaborations, mergers and acquisitions, product launches and approvals, geographical developments, and collaborative efforts are also some of the primary strategies used by major industry players to increase market share.

In May 2021, Cytiva partnered with Multiply Labs, a pioneer in the development of robotic systems for manufacturing pharmaceuticals. The goal of this partnership was to develop a robotic manufacturing system that would automate the manual aspects of the cell therapy manufacturing processes.

In February 2021, Brooks Life Sciences and Cytiva agreed to expand the automated cold chain’s capabilities. The firms are collaborating to improve the cryogenic cold chain capabilities of Cytiva’s automated cold chain technology.

In July 2020, Miltenyi Biotec introduced the CliniMACS Prodigy Adherent Cell Culture System. This technology enables the automated, scalable, & closed production of a wide range of adhesive cell types, including stem cells and their derivatives.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

  • The growing emphasis on regenerative medicines and cell therapies, the range of advantages offered by automation technologies, and an increasing number of technological developments associated with cell therapy processing are key factors propelling the automated and closed cell therapy processing systems market growth.
  • Market segmented by system type, application, end-user, scale, and region.
  • Stem cell therapy is poised for significant growth, especially in regenerative medicine, and CAR-T cell therapy leads the application category, notably in cancer treatment.
  • Pharmaceutical & biotechnology companies are the primary end-users, with academic & research institutions playing a vital role.
  • Large-scale systems are gaining prominence for industrial-scale production, and small-scale systems are essential for research and personalized medicine.
  • The diversification of cell therapy applications, including regenerative medicine, immunotherapy, and gene editing, is broadening the market’s scope.

Future Outlook

  • Growing investments by bio manufacturers in the development of cellular treatment products through a series of funding rounds are expected to provide the market with lucrative growth opportunities.
  • Continuous technological advancements in automation, real-time monitoring, and control systems are propelling the market forward, enabling manufacturers to optimize processes, reduce costs, and enhance product quality.
  • The growing trend toward personalized medicine is expected to boost demand for small-scale automated systems tailored to individualized cell therapy production. These systems will play a crucial role in advancing customized treatments.
  • Emerging markets, particularly in the Asia Pacific region, offer significant growth opportunities driven by expanding healthcare infrastructure, rising investments in research, and increasing adoption of cell therapies.

Segmentation

  • By System Type
    • Cell Expansion Systems
    • Cell Harvesting Systems
    • Cell Separation and Sorting Systems
    • Cell Washing and Concentration Systems
    • Closed System Cryopreservation Systems
    • Others
  • By Application
    • CAR-T Cell Therapy
    • Stem Cell Therapy
    • Other Cell-Based Therapies
  • By End User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutions
    • Hospitals and Clinics
  • By Scale
    • Small-Scale Systems
    • Large-Scale Systems
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Adjacent Markets

Several adjacent markets have high revenue growth opportunities in the automated & closed-cell therapy processing systems market. The key adjacent markets for automated and closed cell therapy processing systems market –

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction

2. Executive Summary
2.1. Market Snapshot: Global Automated and Closed Cell Therapy Processing Systems Market
2.1.1. Global Automated and Closed Cell Therapy Processing Systems Market, By System Type
2.1.2. Global Automated and Closed Cell Therapy Processing Systems Market, By Application
2.1.3. Global Automated and Closed Cell Therapy Processing Systems Market, By End User
2.1.4. Global Automated and Closed Cell Therapy Processing Systems Market, By Scale
2.1.5. Global Automated and Closed Cell Therapy Processing Systems Market, By Region
2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Automated and Closed Cell Therapy Processing Systems Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Automated and Closed Cell Therapy Processing Systems Market Drivers
3.2.2. Automated and Closed Cell Therapy Processing Systems Market Restraints
3.2.3. Automated and Closed Cell Therapy Processing Systems Market Opportunities
3.2.4. Major Automated and Closed Cell Therapy Processing Systems Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. System Type
3.5.2. Application
3.5.3. End User
3.5.4. Scale
3.5.5. Geography

4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Automated and Closed Cell Therapy Processing Systems Market: Company Market Share, Value 2022
4.1.2. Global Automated and Closed Cell Therapy Processing Systems Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Automated and Closed Cell Therapy Processing Systems Market: Top 3 Company Market Share, Value 2022
4.2. Global Automated and Closed Cell Therapy Processing Systems Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Automated and Closed Cell Therapy Processing Systems Market

5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others

7. Impact Analysis of COVID-19 and Russia – Ukraine War on Automated and Closed Cell Therapy Processing Systems Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa

8. Global Automated and Closed Cell Therapy Processing Systems Market, By System Type
8.1. Global Automated and Closed Cell Therapy Processing Systems Market Overview, by System Type
8.1.1. Global Automated and Closed Cell Therapy Processing Systems Market Revenue Share, By System Type, 2022 Vs 2030 (in %)
8.2. Cell Expansion Systems
8.2.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Cell Expansion Systems, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Cell Expansion Systems
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Cell Harvesting Systems
8.3.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Cell Harvesting Systems, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Cell Harvesting Systems
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Cell Separation and Sorting Systems
8.4.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Cell Separation and Sorting Systems, By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Cell Separation and Sorting Systems
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Cell Washing and Concentration Systems
8.5.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Cell Washing and Concentration Systems, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Cell Washing and Concentration Systems
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Closed System Cryopreservation Systems
8.6.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Closed System Cryopreservation Systems, By Region, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Closed System Cryopreservation Systems
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
8.7. Others
8.7.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Others, By Region, 2017-2030 (US$ Mn)
8.7.2. Market Dynamics for Others
8.7.2.1. Drivers
8.7.2.2. Restraints
8.7.2.3. Opportunities
8.7.2.4. Trends

9. Global Automated and Closed Cell Therapy Processing Systems Market, By Application
9.1. Global Automated and Closed Cell Therapy Processing Systems Market Overview, by Application
9.1.1. Global Automated and Closed Cell Therapy Processing Systems Market Revenue Share, By Application, 2022 Vs 2030 (in %)
9.2. CAR-T Cell Therapy
9.2.1. Global Automated and Closed Cell Therapy Processing Systems Market, By CAR-T Cell Therapy, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for CAR-T Cell Therapy
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Stem Cell Therapy
9.3.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Stem Cell Therapy, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Stem Cell Therapy
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Other Cell-Based Therapies
9.4.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Other Cell-Based Therapies, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Other Cell-Based Therapies
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends

10. Global Automated and Closed Cell Therapy Processing Systems Market, By End User
10.1. Global Automated and Closed Cell Therapy Processing Systems Market Overview, by End User
10.1.1. Global Automated and Closed Cell Therapy Processing Systems Market Revenue Share, By End User, 2022 Vs 2030 (in %)
10.2. Pharmaceutical and Biotechnology Companies
10.2.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Academic and Research Institutions
10.3.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Academic and Research Institutions, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Academic and Research Institutions
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Hospitals and Clinics
10.4.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Hospitals and Clinics
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends

11. Global Automated and Closed Cell Therapy Processing Systems Market, By Scale
11.1. Global Automated and Closed Cell Therapy Processing Systems Market Overview, by Scale
11.1.1. Global Automated and Closed Cell Therapy Processing Systems Market Revenue Share, By Scale, 2022 Vs 2030 (in %)
11.2. Small-Scale Systems
11.2.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Small-Scale Systems, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Small-Scale Systems
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Large-Scale Systems
11.3.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Large-Scale Systems, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Large-Scale Systems
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends

12. Global Automated and Closed Cell Therapy Processing Systems Market, By Region
12.1. Global Automated and Closed Cell Therapy Processing Systems Market Overview, by Region
12.1.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Region, 2022 vs 2030 (in%)
12.2. System Type
12.2.1. Global Automated and Closed Cell Therapy Processing Systems Market, By System Type, 2017-2030 (US$ Mn)
12.3. Application
12.3.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Application, 2017-2030 (US$ Mn)
12.4. End User
12.4.1. Global Automated and Closed Cell Therapy Processing Systems Market, By End User, 2017-2030 (US$ Mn)
12.5. Scale
12.5.1. Global Automated and Closed Cell Therapy Processing Systems Market, By Scale, 2017-2030 (US$ Mn)

13. North America Automated and Closed Cell Therapy Processing Systems Market Analysis
13.1. Overview
13.1.1. Market Dynamics for North America
13.1.1.1. Drivers
13.1.1.2. Restraints
13.1.1.3. Opportunities
13.1.1.4. Trends
13.2. North America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. North America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. North America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. North America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
13.5.1. Overview
13.5.2. SRC Analysis
13.6. North America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
13.6.1. North America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
13.6.2. U.S.
13.6.3. Canada
13.6.4. Mexico

14. Europe Automated and Closed Cell Therapy Processing Systems Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. Europe Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Europe Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Europe Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Europe Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. Europe Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
14.6.1. Europe Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
14.6.2. UK
14.6.3. France
14.6.4. Germany
14.6.5. Italy
14.6.6. Spain
14.6.7. Benelux
14.6.8. Russia
14.6.9. Rest of Europe

15. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
15.6.1. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
15.6.2. China
15.6.3. Japan
15.6.4. India
15.6.5. South Korea
15.6.6. South East Asia
15.6.7. Rest of Asia Pacific

16. Latin America Automated and Closed Cell Therapy Processing Systems Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Latin America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Latin America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Latin America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Latin America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Latin America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
16.6.1. Latin America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
16.6.2. Brazil
16.6.3. Argentina
16.6.4. Rest of Latin America

17. Middle East Automated and Closed Cell Therapy Processing Systems Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Middle East Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Middle East Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Middle East Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Middle East Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Middle East Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
17.6.1. Middle East Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
17.6.2. UAE
17.6.3. Saudi Arabia
17.6.4. Rest of Middle East

18. Africa Automated and Closed Cell Therapy Processing Systems Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Africa Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2030 (US$ Mn)
18.6.1. Middle East Automated and Closed Cell Therapy Processing Systems Market, by Country, 2022 Vs 2030 (in%)
18.6.2. South Africa
18.6.3. Egypt
18.6.4. Rest of Africa

19. Company Profiles
19.1. Miltenyi Biotec
19.1.1. Company Overview
19.1.2. Products/Services Portfolio
19.1.3. Geographical Presence
19.1.4. SWOT Analysis
19.1.5. Financial Summary
19.1.5.1. Market Revenue and Net Profit (2019-2022)
19.1.5.2. Business Segment Revenue Analysis
19.1.5.3. Geographical Revenue Analysis
19.2. Lonza
19.3. Fresenius Kabi
19.4. Cytiva (Danaher Corp.)
19.5. BioSpherix Ltd
19.6. Terumo Corp.
19.7. Sartorius AG
19.8. ThermoGenesis Holdings Inc
19.9. Cellares Inc
19.10. Thermo Fisher Scientific Inc
19.11. Others

20. Research Methodology
20.1. Research Methodology
20.2. Phase I – Secondary Research
20.3. Phase II – Data Modelling
20.3.1. Company Share Analysis Model
20.3.2. Revenue Based Modelling
20.4. Phase III – Primary Research
20.5. Research Limitations
20.5.1. Assumptions

 

List of Figures
FIG. 1 Global Automated and Closed Cell Therapy Processing Systems Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Automated and Closed Cell Therapy Processing Systems Market Segmentation
FIG. 4 Global Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2022 (US$ Mn)
FIG. 5 Global Automated and Closed Cell Therapy Processing Systems Market, by Application, 2022 (US$ Mn)
FIG. 6 Global Automated and Closed Cell Therapy Processing Systems Market, by End User, 2022 (US$ Mn)
FIG. 7 Global Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2022 (US$ Mn)
FIG. 8 Global Automated and Closed Cell Therapy Processing Systems Market, by Geography, 2022 (US$ Mn)
FIG. 9 Attractive Investment Proposition, by System Type, 2022
FIG. 10 Attractive Investment Proposition, by Application, 2022
FIG. 11 Attractive Investment Proposition, by End User, 2022
FIG. 12 Attractive Investment Proposition, by Scale, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Automated and Closed Cell Therapy Processing Systems Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Automated and Closed Cell Therapy Processing Systems Market Manufacturers, 2022
FIG. 16 Global Automated and Closed Cell Therapy Processing Systems Market Value Contribution, By System Type, 2022 & 2030 (Value %)
FIG. 17 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Expansion Systems, Value, 2017-2030 (US$ Mn)
FIG. 18 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Harvesting Systems, Value, 2017-2030 (US$ Mn)
FIG. 19 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Separation and Sorting Systems, Value, 2017-2030 (US$ Mn)
FIG. 20 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Washing and Concentration Systems, Value, 2017-2030 (US$ Mn)
FIG. 21 Global Automated and Closed Cell Therapy Processing Systems Market, by Closed System Cryopreservation Systems, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Automated and Closed Cell Therapy Processing Systems Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 23 Global Automated and Closed Cell Therapy Processing Systems Market, by CAR-T Cell Therapy, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Automated and Closed Cell Therapy Processing Systems Market, by Stem Cell Therapy, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Automated and Closed Cell Therapy Processing Systems Market, by Other Cell-Based Therapies, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Automated and Closed Cell Therapy Processing Systems Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 27 Global Automated and Closed Cell Therapy Processing Systems Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Automated and Closed Cell Therapy Processing Systems Market, by Academic and Research Institutions, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Automated and Closed Cell Therapy Processing Systems Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Automated and Closed Cell Therapy Processing Systems Market Value Contribution, By Scale, 2022 & 2030 (Value %)
FIG. 31 Global Automated and Closed Cell Therapy Processing Systems Market, by Small-Scale Systems, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Automated and Closed Cell Therapy Processing Systems Market, by Large-Scale Systems, Value, 2017-2030 (US$ Mn)
FIG. 33 North America Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 34 U.S. Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 35 Canada Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 36 Mexico Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 37 Europe Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 38 Germany Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 39 France Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 40 U.K. Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 41 Italy Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 42 Spain Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 43 Benelux Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 44 Russia Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 45 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 46 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 47 China Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 48 Japan Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 49 India Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 50 South Korea Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 51 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 52 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 53 Latin America Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 54 Brazil Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 55 Argentina Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 57 Middle East Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 58 UAE Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 59 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 60 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 61 Africa Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 62 South Africa Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 63 Egypt Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)
FIG. 64 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, 2017-2030 (US$ Mn)

 

List of Tables
TABLE 1 Market Snapshot: Global Automated and Closed Cell Therapy Processing Systems Market
TABLE 2 Global Automated and Closed Cell Therapy Processing Systems Market: Market Drivers Impact Analysis
TABLE 3 Global Automated and Closed Cell Therapy Processing Systems Market: Market Restraints Impact Analysis
TABLE 4 Global Automated and Closed Cell Therapy Processing Systems Market, by Competitive Benchmarking, 2022
TABLE 5 Global Automated and Closed Cell Therapy Processing Systems Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Automated and Closed Cell Therapy Processing Systems Market, by Key Strategies Analysis, 2022
TABLE 7 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Expansion Systems, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Expansion Systems, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Harvesting Systems, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Harvesting Systems, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Separation and Sorting Systems, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Separation and Sorting Systems, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Washing and Concentration Systems, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Automated and Closed Cell Therapy Processing Systems Market, by Cell Washing and Concentration Systems, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Automated and Closed Cell Therapy Processing Systems Market, by Closed System Cryopreservation Systems, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Automated and Closed Cell Therapy Processing Systems Market, by Closed System Cryopreservation Systems, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Automated and Closed Cell Therapy Processing Systems Market, by CAR-T Cell Therapy, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Automated and Closed Cell Therapy Processing Systems Market, by CAR-T Cell Therapy, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Automated and Closed Cell Therapy Processing Systems Market, by Stem Cell Therapy, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Automated and Closed Cell Therapy Processing Systems Market, by Stem Cell Therapy, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Automated and Closed Cell Therapy Processing Systems Market, by Other Cell-Based Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Automated and Closed Cell Therapy Processing Systems Market, by Other Cell-Based Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Automated and Closed Cell Therapy Processing Systems Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Automated and Closed Cell Therapy Processing Systems Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Automated and Closed Cell Therapy Processing Systems Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Automated and Closed Cell Therapy Processing Systems Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Automated and Closed Cell Therapy Processing Systems Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Automated and Closed Cell Therapy Processing Systems Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Automated and Closed Cell Therapy Processing Systems Market, by Small-Scale Systems, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Automated and Closed Cell Therapy Processing Systems Market, by Small-Scale Systems, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Automated and Closed Cell Therapy Processing Systems Market, by Large-Scale Systems, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Automated and Closed Cell Therapy Processing Systems Market, by Large-Scale Systems, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 34 Global Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 35 Global Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 36 Global Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 37 Global Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 38 Global Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 39 Global Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 40 Global Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 41 Global Automated and Closed Cell Therapy Processing Systems Market, by Region, 2017-2022 (US$ Mn)
TABLE 42 Global Automated and Closed Cell Therapy Processing Systems Market, by Region, 2023-2030 (US$ Mn)
TABLE 43 North America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 44 North America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 45 North America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 46 North America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 47 North America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 48 North America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 49 North America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 50 North America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 51 North America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2022 (US$ Mn)
TABLE 52 North America Automated and Closed Cell Therapy Processing Systems Market, by Country, 2023-2030 (US$ Mn)
TABLE 53 United States Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 54 United States Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 55 United States Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 56 United States Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 57 United States Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 58 United States Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 59 United States Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 60 United States Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 61 Canada Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 62 Canada Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 63 Canada Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 64 Canada Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 65 Canada Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 66 Canada Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 67 Canada Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 68 Canada Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 69 Mexico Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 70 Mexico Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 71 Mexico Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 72 Mexico Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 73 Mexico Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 74 Mexico Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 75 Mexico Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 76 Mexico Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 77 Europe Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 78 Europe Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 79 Europe Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 80 Europe Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 81 Europe Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 82 Europe Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 83 Europe Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 84 Europe Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 85 Europe Automated and Closed Cell Therapy Processing Systems Market, by Country, 2017-2022 (US$ Mn)
TABLE 86 Europe Automated and Closed Cell Therapy Processing Systems Market, by Country, 2023-2030 (US$ Mn)
TABLE 87 Germany Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 88 Germany Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 89 Germany Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 90 Germany Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 91 Germany Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 92 Germany Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 93 Germany Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 94 Germany Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 95 France Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 96 France Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 97 France Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 98 France Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 99 France Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 100 France Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 101 France Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 102 France Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 103 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 104 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 105 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 106 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 107 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 108 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 109 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 110 United Kingdom Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 111 Italy Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 112 Italy Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 113 Italy Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 114 Italy Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 115 Italy Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 116 Italy Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 117 Italy Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 118 Italy Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 119 Spain Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 120 Spain Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 121 Spain Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 122 Spain Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 123 Spain Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 124 Spain Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 125 Spain Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 126 Spain Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 127 Benelux Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 128 Benelux Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 129 Benelux Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 130 Benelux Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 131 Benelux Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 132 Benelux Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 133 Benelux Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 134 Benelux Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 135 Russia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 136 Russia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 137 Russia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 138 Russia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 139 Russia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 140 Russia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 141 Russia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 142 Russia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 143 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 144 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 145 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 146 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 147 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 148 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 149 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 150 Rest of Europe Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 151 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 152 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 153 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 154 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 155 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 156 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 157 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 158 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 159 China Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 160 China Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 161 China Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 162 China Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 163 China Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 164 China Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 165 China Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 166 China Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 167 Japan Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 168 Japan Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 169 Japan Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 170 Japan Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 171 Japan Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 172 Japan Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 173 Japan Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 174 Japan Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 175 India Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 176 India Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 177 India Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 178 India Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 179 India Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 180 India Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 181 India Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 182 India Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 183 South Korea Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 184 South Korea Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 185 South Korea Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 186 South Korea Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 187 South Korea Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 188 South Korea Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 189 South Korea Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 190 South Korea Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 191 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 192 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 193 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 194 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 195 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 196 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 197 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 198 South-East Asia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 199 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 200 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 201 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 202 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 203 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 204 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 205 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 206 Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 207 Latin America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 208 Latin America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 209 Latin America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 210 Latin America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 211 Latin America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 212 Latin America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 213 Latin America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 214 Latin America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 215 Brazil Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 216 Brazil Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 217 Brazil Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 218 Brazil Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 219 Brazil Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 220 Brazil Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 221 Brazil Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 222 Brazil Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 223 Argentina Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 224 Argentina Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 225 Argentina Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 226 Argentina Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 227 Argentina Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 228 Argentina Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 229 Argentina Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 230 Argentina Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 231 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 232 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 233 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 234 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 235 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 236 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 237 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 238 Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 239 Middle East Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 240 Middle East Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 241 Middle East Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 242 Middle East Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 243 Middle East Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 244 Middle East Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 245 Middle East Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 246 Middle East Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 247 UAE Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 248 UAE Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 249 UAE Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 250 UAE Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 251 UAE Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 252 UAE Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 253 UAE Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 254 UAE Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 255 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 256 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 257 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 258 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 259 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 260 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 261 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 262 Saudi Arabia Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 263 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 264 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 265 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 266 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 267 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 268 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 269 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 270 Rest of Middle East Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 271 Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 272 Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 273 Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 274 Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 275 Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 276 Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 277 Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 278 Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 279 South Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 280 South Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 281 South Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 282 South Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 283 South Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 284 South Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 285 South Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 286 South Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 287 Egypt Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 288 Egypt Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 289 Egypt Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 290 Egypt Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 291 Egypt Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 292 Egypt Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 293 Egypt Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 294 Egypt Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)
TABLE 295 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2017-2022 (US$ Mn)
TABLE 296 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by System Type, 2023-2030 (US$ Mn)
TABLE 297 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2017-2022 (US$ Mn)
TABLE 298 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by Application, 2023-2030 (US$ Mn)
TABLE 299 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2017-2022 (US$ Mn)
TABLE 300 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by End User, 2023-2030 (US$ Mn)
TABLE 301 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2017-2022 (US$ Mn)
TABLE 302 Rest of Africa Automated and Closed Cell Therapy Processing Systems Market, by Scale, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current size of the global automated & closed-cell therapy processing systems market?

The global automated and closed cell therapy processing systems market was valued at USD 944.9 Million in 2022.

What is the expected growth rate of the automated & closed-cell therapy processing systems market between 2023 and 2030?

The automated & closed-cell therapy processing systems market is expected to grow at a CAGR of 18.5% between 2023 and 2030, reaching USD 3673.9 Million in 2030.

Which segment is leading the market share in terms of system type?

Cell expansion systems are the leading segment by system type, holding over 30% share in value in 2022.

Which application segment governs the global demand for automated and closed cell therapy processing systems?

The CAR-T cell therapy segment governs the global demand for automated and closed cell therapy processing systems, holding a massive market share of over 44% in 2022.

Which end-user segment will post the highest CAGR in the forecast period?

The academic & research institutions segment will post the highest CAGR over the projection period.

Which region is fueling the growth of the automated and closed cell therapy processing systems industry?

North America contributes to the rapid growth of the automated and closed cell therapy processing systems industry, accounting for more than one-third of its market share in 2022.

Who are the major players in the global automated and closed cell therapy processing systems market?

The top players include Lonza, Miltenyi Biotec, Cytiva (Danaher Corp.), Fresenius Kabi, Terumo Corp., BioSpherix Ltd, ThermoGenesis Holdings Inc, Sartorius AG, Thermo Fisher Scientific Inc, Cellares Inc, and Others.

What are the major market drivers of the automated and closed cell therapy processing systems industry?

The major market drivers of the automated and closed cell therapy processing systems industry are the increasing adoption of cell-based therapies and continuous technological advancements to enhance manufacturing processes.

What are the major market restraints of the automated and closed cell therapy processing systems industry?

The major market restraints of the automated and closed cell therapy processing systems industry include high initial investment costs and complex regulatory compliance requirements.

What are the major market opportunities of the automated and closed cell therapy processing systems industry?

The major market opportunities of the automated and closed cell therapy processing systems industry include expansion into emerging markets, particularly in regions like the Asia Pacific, and innovation in single-use technologies to improve system efficiency and cost-effectiveness.

Related Reports

Latin America Veterinary Imaging Market

Published:
Report ID: 38233

Japan Artificial Intelligence (AI) in medical diagnostics market

Published:
Report ID: 38197

Colorectal Cancer (CRC) Market

Published:
Report ID: 37220

US Dental Equipment Market

Published:
Report ID: 37218

AI in Medical Diagnostics Market

Published:
Report ID: 38121

India Insulin Pump Market

Published:
Report ID: 38098

DNA Sequencing Market

Published:
Report ID: 38067

Digital X-Ray Market

Published:
Report ID: 38063

Medical Tourism Market

Published:
Report ID: 38049

Veterinary Endoscopy Market

Published:
Report ID: 37850

Veterinary Artificial Insemination Market

Published:
Report ID: 37847

Europe Veterinary Imaging Market

Published:
Report ID: 37843

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.

Request Free Sample

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
Request Free Sample